Tetravalent rhesus rotavirus vaccine in young infants

Journal of Infectious Diseases

Volumn 170, Issue 5, 1994, Pages 1260-1263

  Kobayashi, Masaaki ^a,b   Thompson, Juliette ^a   Tollefson, Sharon J ^a   Reed, George W ^a   Wright, Peter F ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CITRATE SODIUM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; LIVE VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; ROTAVIRUS VACCINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE RESPONSE; INFANT; INFANTILE DIARRHEA; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PLAQUE FORMING CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; SINGLE BLIND PROCEDURE; VACCINATION; VIRUS NEUTRALIZATION; VIRUS SHEDDING; VIRUS STRAIN;

ADMINISTRATION, ORAL; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 0028020604     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.5.1260     Document Type: Article

References (16)

1. Brandt CD, Kim HW, Rodriquez JO, et al. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol 1983;18:71-8.
2. LeBaron CW, Lew J, Glass RI, et al. Annual rotavirus epidemic patterns in North America. JAMA 1990;264:983-8.
3. Midthun K, Greenberg HB, Hosino Y, et al. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 1985;53:949-54.
4. Wright PF, Tajima T, Thompson J, et al. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: An evaluation. Pediatrics 1987;80:473-80.
5. Tajima T. Thompson J, Wright PF, et al. Evaluation of a reassortant rhesus rotavirus vaccinc in young children. Vaccine 1990;8:70-4.
6. Wright PF, King J, Araki K, et al. Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children. J Infect Dis 1991; 164:271-6.
7. Kobayashi MK, Araki K, Thompson J, et al. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children J Infect Dis 1993;167:48-52.
8. Flores J, Perez-Schael I, Gonzalez M, et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987;1:882-4.
9. Vesikari T, Ruuska T, Green K, et al. Protective efficacy against serotype I rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype I or 2 specificity. Pediatr Infect Dis J 1992;11:535-42.
10. Taniguchi K, Urasawa T. Morita Y, Greenberg HB. Urasawa S. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype I-. 2-. 3-. and 4-specific monoclonal antibodies to VP7. J Infect Dis 1987; 155:1 159-66.
11. Perez-Schael I, Blanco M, Vilar M, et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28:553-8.
12. Lawton AR. Immunization of the neonate. Int J Technol Assess Health Care 1994 (in press).
13. Dagan R, Kassis I, Sarov B. et al. Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates. Pediatr Infect Dis J 1992;11:991-6.
14. Chiba S. Nakata S. Urasawa T. et al. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1986;2:417-21.
15. Gorziglia M, Larralde G, Kapikian AZ, Chanock RM. Antigenic relationships among human rotaviruses as determined by outer membrane capsid protein VP4. Proc Natl Acad Sci USA 1990;87:7151-9.
16. Sack D, US Rotavirus Vaccine Efficacy Group. Efficacy of rhesus rotavirus monovalent or tetravalent oral vaccines in US children [abstract 1399]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington. DC: American Society for Microbiology, 1992:344.